The distinct contributions of murine T cell receptor (TCR)γδ + and TCRαβ+ T cells to different stages of chemically induced skin cancer

Journal of Experimental Medicine

Volumn 198, Issue 5, 2003, Pages 747-755

  Girardi, Michael ^a   Glusac, Earl ^a   Filler, Renata B ^a   Roberts, Scott J ^a   Propperova, Iva ^c   Lewis, Julia ^a   Tigelaar, Robert E ^a,b   Hayday, Adrian C ^d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^d GUY S HOSPITAL   (United Kingdom)

Author keywords

Carcinogenesis; Immunogenetics; Squamous cell carcinoma; TCR ; TCR

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; PHORBOL 13 ACETATE 12 MYRISTATE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL TYPE; CONTROLLED STUDY; DISEASE ACTIVITY; EPITHELIUM; IMMUNOGENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SKIN CANCER; SKIN PAPILLOMA; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; DISEASE MODELS, ANIMAL; HEMATOPOIETIC STEM CELLS; LIVER; MICE; MICE, KNOCKOUT; NEOPLASM STAGING; PAPILLOMA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SKIN NEOPLASMS; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS;

EID: 0041884744     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20021282     Document Type: Article

References (21)

1. Peto, J. 2001. Cancer epidemiology in the last century and the next decade. Nature. 411:390-395.
2. Pentland, A.P., J.W. Schoggins, G.A. Scott, K.N. Khan, and R. Han. 1999. Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis. 20:1939-1944.
3. Orengo, I.F., J. Gerguis, R. Phillips, A. Guevara, A.T. Lewis, and H.S. Black. 2002. Celecoxib, a cyclooxygenase 2 inhibitor as a potential chemopreventive to UV-induced skin cancer: a study in the hairless mouse model. Arch. Dermatol. 138:751-755.
4. Ferguson, A. 1977. Intraepithelial lymphocytes of the small intestine. Gut. 18:921-937.
5. Hayday, A., E. Theodoridis, E. Ramsburg, and J. Shires. 2001. Intraepithelial lymphocytes: exploring the Third Way in immunology. Nat. Immunol. 2:997-1003.
6. + intraepithelial lymphocytes provided by serial analysis of gene expression (SAGE). Immunity. 15:419-434.
7. Fahrer, A.M., Y. Konigshofer, E.M. Kerr, G. Ghandour, D.H. Mack, M.M. Davis, and Y.H. Chien. 2001. Attributes of gamma delta intraepithelial lymphocytes as suggested by their transcriptional profile. Proc. Natl. Acad. Sci. USA. 98:10261-10266.
8. + dendritic epidermal cells. Cell. 55:837-847.
9. Girardi, M., J. Lewis, E. Glusac, R.B. Filler, L. Geng, A.C. Hayday, and R.E. Tigelaar. 2002. Resident skin-specific gamma delta T cells provide local, nonredundant regulation of cutaneous inflammation. J. Exp. Med. 195:855-867.
10. Boismenu, R., and W.L. Havran. 1994. Modulation of epithelial cell growth by intraepithelial gamma delta T cells. Science. 266:1253-1255.
11. Girardi, M., D.E. Oppenheim, C.R. Steele, J.M. Lewis, E. Glusac, R. Filler, P. Hobby, B. Sutton, R.E. Tigelaar, and A.C. Hayday. 2001. Regulation of cutaneous malignancy by gamma delta T cells. Science. 294:605-609.
12. Siegel, C.T., K. Schreiber, S.C. Meredith, G.B. Beck-Engeser, D.W. Lancki, C.A. Lazarski, Y.X. Fu, D.A. Rowley, and H. Schreiber. 2000. Enhanced growth of primary tumors in cancer-prone mice after immunization against the mutant region of an inherited oncoprotein. J. Exp. Med. 191:1945-1956.
13. + T cells. J. Exp. Med. 197:1017-1028.
14. Hennings, H., A.B. Glick, D.T. Lowry, L.S. Krsmanovic, L.M. Sly, and S. Yuspa. 1993. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis. 14:2353-2358.
15. Peng, S.L., M.E. Robert, A.C. Hayday, and J. Craft. 1996. A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient Mice. J. Exp. Med. 184:1149-1154.
16. Rosenberg, S.A., J.C. Yang, D.J. Schwartzentruber, P. Hwu, F.M. Marincola, S.L. Topalian, N.P. Restifo, M.E. Dudley, S.L. Schwarz, P.J. Spiess, et al. 1998. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4:321-327.
17. + progenitor-derived dendritic cell vaccine. Cancer Res. 61:6451-6458.
18. Williams, I.R., R.J. Ort, D. Daley, L. Manning, T. Karaoli, R.L. Barnhill, and T.S. Kupper. 1996. Constitutive expression of B7-1 (CD80) on mouse keratinocytes does not prevent development of chemically induced skin papillomas and carcinomas. J. Immunol. 156:3382-3388.
19. Coussens, L.M., C.L. Tinkle, D. Hanahan, and Z. Werb. 2000. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 103:481-490.
20. Holtmeier, W., M. Pfander, A. Hennemann, T.M. Zollner, R. Kaufmann, and W.F. Caspary. 2001. The TCR,-delta repertoire in normal human skin is restricted and distinct from the TCR,-delta repertoire in the peripheral blood. J. Invest. Dermatol. 116:275-280.
21. Groh, V., R. Rhinehart, H. Secrist, S. Bauer, K.H. Grabstein, and T. Spies. 1999. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA. 96:6879-6884.